title: Is age at initiation of extracorporeal life support associated with mortality and intraventricular hemorrhage in neonates with respiratory failure?
abstract: OBJECTIVE
  To describe differences in characteristics among neonates treated with extracorporeal life support (ECLS) in the first week of life for respiratory failure compared with later in the neonatal period and to assess risk factors for central nervous system (CNS) hemorrhage and mortality among the two groups.
  
  
  METHODS
  Review of the Extracorporeal Life Support Organization registry from 2001 to 2010 of neonates ⩽30 days comparing two age groups: those ⩽7 days (Group 1) to those >7 days (Group 2) at ECLS initiation.
  
  
  RESULTS
  Among 4888 neonates, Group 1 (n=4453) had significantly lower mortality (17 vs 39%, P<0.001) but greater CNS hemorrhage (11 vs 7%, P=0.02) than Group 2 (n=453). Mortality and CNS hemorrhage improved significantly with increasing gestational age only for Group 1 patients. CNS hemorrhage occurred more frequently in Group 1 patients receiving venoarterial (VA) than with venovenous ECLS (15 vs 7%, P<0.001). In Group 1, lower birth weight and pre-ECLS pH and VA mode were independently associated with mortality. In Group 2, higher mean airway pressure was independently associated with mortality. Complications of ECLS therapy, including CNS hemorrhage and renal replacement therapy were independently associated with mortality for both groups.
  
  
  CONCLUSIONS
  Neonates cannulated for ECLS after the first week of life had greater mortality despite lower CNS hemorrhage than neonates receiving ECLS earlier. Premature infants cannulated after 1 week had fewer CNS hemorrhages than premature infants treated with extracorporeal membrane oxygenation starting within the first week of life.
authors.affiliation: Divisions of Neonatology, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: K M
authors.initials: KM
authors.lastname: Smith
authors.affiliation: Pediatric Cardiovascular Surgery, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: McMullan
authors.affiliation: Primary Children's Hospital, Salt Lake City, UT, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Bratton
authors.affiliation: Extracorporeal Life Support Organization, the University of Michigan, Ann Arbor, MI, USA.
authors.forename: P
authors.initials: P
authors.lastname: Rycus
authors.affiliation: University of Colorado School of Medicine and the Childrens Hospital, Aurora, CO, USA.
authors.forename: J P
authors.initials: JP
authors.lastname: Kinsella
authors.affiliation: Pediatric Critical Care Medicine, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: T V
authors.identifier: 0000000284240831
authors.initials: TV
authors.lastname: Brogan
mesh_terms: D002543:Cerebral Hemorrhage / Q000209:etiology*; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects / Q000401:mortality*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000401:mortality*; D008020:Life Support Care; D012131:Respiratory Insufficiency / Q000150:complications / Q000401:mortality / Q000628:therapy*